The Advisors Team at Sigilon Therapeutics provides strategic guidance and expert insights to support the development and implementation of innovative therapies involving immune-protected, engineered human cells. Their expertise helps navigate scientific, clinical, and regulatory challenges to further the company's mission of treating serious chronic diseases.
View all